API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215719
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215384
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-26-2023-55742.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-loteprednol-etabonate-ophthalmic-gel-94298.pdf
https://www.biospace.com/article/releases/alcon-to-acquire-eysuvis-adding-to-its-ophthalmic-eye-drop-portfolio/
https://www.fiercepharma.com/pharma/kala-buys-time-selling-eye-disease-drugs-alcon-60m
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212080
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212080
https://www.prnewswire.com/news-releases/akorn-receives-fda-approval-for-loteprednol-etabonate-ophthalmic-gel-0-5-301226986.html
https://www.pharmacompass.com/pdf/news/farmabios-spa-fails-edqm-inspection-1575005454.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207609
https://www.businesswire.com/news/home/20181003005271/en/Kala-Pharmaceuticals-Announces-Pricing-Public-Offering-7500000
https://www.reuters.com/article/us-kala-pharms-fda/fda-approves-kala-pharmas-eye-pain-drug-idUSKCN1L82BY
http://www.biospace.com/News/massachusetts-mucus-penetrating-eye-disease-firm/415386/source=TopBreaking
http://www.prnewswire.com/news-releases/valeant-announces-new-us-fulfillment-agreements-with-walgreens-plans-to-further-extend-distribution-to-independent-pharmacies-300192840.html